The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai

Ha Kyun Chang; Byoung-Gie Kim; Ting-Yan Shi; Rongyu Zang

doi:10.3802/jgo.2016.27.e64

Journal List > J Gynecol Oncol > v.27(6) > 1093788

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Chang, Kim, Shi, and Zang: The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai

Meeting Report

J Gynecol Oncol 2016;27(6):e64.

Published online: 4 November 2016

DOI: https://doi.org/10.3802/jgo.2016.27.e64

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) joint meeting and 2016 Asia-Pacific Ovarian cancer Laparotomy and Laparoscopic Operation (APOLLO) symposium in Shanghai

Ha Kyun Chang¹, Byoung-Gie Kim², Ting-Yan Shi³, Rongyu Zang^3,

¹Department of Obstetrics and Gynecology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea

²Department of Obstetrics and Gynecology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

³Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai, China

Correspondence to Rongyu Zang Department of Obstetrics and Gynecology, Zhongshan Hospital, Fudan University, Shanghai 200032, China. E-mail: ryzang@yahoo.com

Received 8 August 2016 Accepted 8 August 2016

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Fig. 1.

The 5th Shanghai Gynecologic Oncology Group (SGOG)-Korean Gynecologic Oncology Group (KGOG) Joint Meeting. Dong Hoon Suh (upper from the left), Taek Sang Lee, E Sun Paik, Jin Young Choi, Kidong Kim, Sheng Yin, Pan Wang, Wen Gao, Di Shi, Boer Shan, Ha Kyun Chang (middle from the left), Youngjae Lee, Jae-Weon Kim, Byoung-Gie Kim, Sang-Yoon Park, Michael Bookman, Rongyu Zang, Yong-Man Kim, Jianqing Zhu, Yincheng Teng, He Huang, Misun Kim (lower from the left), Jung Yeon Park, Minhee Shim, Huaying Wang, Xiaojun Chen, Lihua Qiu, Rong Zhang, Bingyi Yang, Yuting Luan, Rong Jiang, Ting-Yan Shi, and Jianxin Yao.

Fig. 2.

The 1st to 4th Korean Gynecologic Oncology Group (KGOG)-Shanghai Gynecologic Oncology Group (SGOG) Joint Meetings. (A) First meeting in Seoul during the 10th Asian Clinical Oncology Society (ACOS) June 13, 2012, (B) 2nd meeting in Shanghai, December 8, 2012, (C) 3rd meeting in Shanghai, September 18 to 19, 2014, and (D) 4th meeting in Seoul during the 4th Asian Society of Gynecologic Oncology (ASGO), November 12, 2015.

Fig. 3.

2016 Asia-Pacific Ovarian Cancer Laparotomy and Laparoscopic Operation (APOLLO) Symposium in Shanghai.

Table 1.

The 5th SGOG-KGOG Joint Meeting

Date and place	Attendee	Agenda
June 18, 2016, Shanghai, China	SGOG member: Rongyu Zang, Jianqing Zhu, Xiaojun Chen, Xi-Peng Wang, Wen Gao, He Huang, Wei Zhang, Huaying Wang, Li Hua Qiu, Zi-Yong Xiang, Boer Shan, Bing-Yi Yang, Ting-Yan Shi, Rong Jiang, Yuting Luan	SGOG SUNNY trial (Rong Jiang) Prediction of response to neoadjuvant chemotherapy by PET-CT in advanced-stage ovarian cancer (Ha Kyun Chang) Predict lymph node metastasis in endometrial cancer by PR, Ki67, and cancer, SGOG (Xiaojun Chen) Prospective study evaluating a strategy of surgery alone and surveillance in FIGO stage I malignant ovarian germ cell tumor (KGOG 3033) (Jeong-Yeol Park) SGOG SUNNY cooperation: contract including the authorship (Rongyu Zang, Byoung-Gie Kim, Sang-Yoon Park) SGOG-KGOG history and future cooperation (Jae-Weon Kim) SGOG SUNNY: data management, e-CRF (Zi-Yong Xiang) SGOG SUNNY: randomization (Wei Zhang) KGOG data management (Kidong Kim)
June 18, 2016, Shanghai, China	KGOG member: Byoung-Gie Kim, Jae-Weon Kim, Sang-Yoon Park, Yong-Man Kim, Taek Sang Lee, Kidong Kim, Jeong-Yeol Park^, Hee-Seung Kim^, Dong Hoon Suh^, Jongsoon Kim, Miram Jang, Minseo Kim, Myung-Hee Nam, Seungmee Lee^, Misun Kim^, Jin Young Choi^, E Sun Paik^, Minhee Shim^, Ha Kyun Chang^, Youngjae Lee^, Jung Yeon Park^*

CRF, clinical report form; FIGO, International Federation of Gynecology and Obstetrics; KGOG, Korean Gynecologic Oncology Group; PET-CT, positron emission tomography-computed tomography; PR, progesterone receptor; SGOG, Shanghai Gynecologic Oncology Group; SUNNY, study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer.

^* Young doctors from KGOG.

Table 2.

History of KGOG-SGOG Joint Meetings

KGOG-SGOG meeting	Attendee	Agenda
1st KGOG-SGOG (June 13, 2012, Seoul, Korea)	KGOG member: Joo-Hyun Nam, Jae-Weon Kim, Jae-Hoon Kim, Byoung-Gie Kim, Sang-Young Ryu, Sokbom Kang, Dong Hoon Suh, Yoo-Kyung Lee SGOG member: Rongyu Zang	Introduction of KGOG and SGOG (Jae-Hoon Kim) KGOG 2014, 2015 (Sokbom Kang) KGOG 3019 (Byoung-Gie Kim) SGOG ongoing trials and related activities (Rongyu Zang) GOG263, TACO (Sang-Young Ryu)
2nd SGOG-KGOG (December 8, 2012, Shanghai, China)	SGOG member: Jing-He Lang, Rongyu Zang, Wen Di, Ji-Hong Liu, Xian-Jie Tan, Quan Hao, Xiaojun Chen, Xi Cheng, Xi-Peng Wang, Boer Shan, Xiao Huang, Bei-Hua Kong, Xiao-Ping Wan, Hong Sun, Yin-Cheng Teng, Jianqing Zhu, Ping Zhang, Hua Jiang, Ya-Ping Zhu, Li-Hua Qiu, Jin-jin Yu, Zhi-Yuan Dai, Xia Wu, Ting-Yan Shi, Shu Shan KGOG member: Soon-Beom Kang, Jae-Hoon Kim, Jae-Weon Kim, Sang-Young Ryu, Dong Hoon Suh	Ovarian cancer trials and translational research within SGOG (Rongyu Zang) Ovarian cancer trials and translational research of KGOG (Jae-Hoon Kim) Introduction of Peking Union Medical College Hospital (Xian-Jie Tan) International clinical trials on cervical cancer and TACO trial (Sang-Young Ryu) Metabolic syndrome and endometrial cancer (Xiao-Jun Chen) Prospective observational study for the validation of preoperative low-risk criteria for LN metastasis in endometrial cancer (Jae-Weon Kim) Data flow in KGOG trials and e-Velos system (Dong Hoon Suh) Post-GWAS collaborations of ovarian cancer (Ting-Yan Shi)
3rd SGOG-KGOG (September 19–20, 2014, Shanghai, China)	SGOG member: Jie Jiang, Heng Cui, Jihong Liu, Xiu-Gui Sheng, Jianqing Zhu, Ping Zhang, Wen Gao, Hong Pu, Xiaojun Chen, Xin Lu, Xi-Peng Wang, Yaping Zhu, Zhi-Yuan Dai, Hua-Ying Wang, Xiao Huang, Yan-Fei Liu, Rongyu Zang, Jun Guan, Rong Jiang, Bing-Yi Yang, Ting-Yan Shi, Yun-Lang Cai, Chun-Lin Chen KGOG member: Joo-Hyun Nam, Byoung-Gie Kim, Jae-Hoon Kim, Jae-Weon Kim, Sokbom Kang, Sang-Young Ryu	KGOG 1029 (Joo-Hyun Nam) SGOG OV2 (SMART2) (Rong Jiang) KGOG TACO (Sang-Young Ryu) SGOG OV1 (SMART1) (Rong Jiang) SGOG SMART1 phase II to phase III (Rong Jiang) SGOG OV3, OV4A, OV4B (Rongyu Zang) KGOG2015 (Sokbom Kang) ECCO and SGOG possible participators (Byoung-Gie Kim) SGOG-KGOG Cooperation Concept (Byoung-Gie Kim, Rongyu Zang)
4th KGOG-SGOG (November 12, 2015, Seoul, Korea)	KGOG member: Soon-Beom Kang, Joo-Hyun Nam, Byoung-Gie Kim, Jae-Hoon Kim, Jae-Weon Kim, Sang-Young Ryu, Sang-Wun Kim, Dong Hoon Suh, Jeong-Yeol Park, Yoo-Young Lee SGOG member: Rongyu Zang, Xiaojun Chen, Xi-Peng Wang, Ji-Hong Liu	SOTO study, searching an optimal third-line chemo+/ anti-angiogenic therapy in ovarian cancer (Sang-Wun Kim) The SUNNY trial, a phase 3 randomized study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery in ovarian cancer (Rongyu Zang) Phase II study of fertility-sparing management using high-dose oral progestin in young women with stage I endometrial adenocarcinoma, grade 2 or superficial myometrial invasion (Jeong-Yeol Park) The effect of metformin combined with megestrol acetate in conservative treatment of early stage endometrial cancer and endometrial atypical hyperplasia: a multicenter randomized control trial (Xiaojun Chen)

ECCO, European Cancer Organisation; GOG, Gynecologic Oncology Group; GWAS, genome-wide association study; KGOG, Korean Gynecologic Oncology Group; LN, lymph node; OV, ovary; SGOG, Shanghai Gynecologic Oncology Group; SOTO, searching an optimal chemo/anti-angiogenic therapy in platinum resistant ovarian cancer; SUNNY, study of upfront surgery versus neoadjuvant chemotherapy followed by interval debulking surgery for patients with stage IIIC and IV ovarian cancer; SMART1, a phase II, randomized study of an addition intraperitoneal cisplatin and etoposide to standard first-line therapy in stage IIIC and stage IV epithelial ovarian, fallopian tube and primary peritoneal cancer; SMART2, a phase II/III study to evaluate the efficacy of secondary cytoreduction in platinum-sensitive recurrent ovarian cancer; TACO, tri-weekly administration of cisplatin in locally advanced cervical cancer study.

TOOLS

Similar articles